Seeing Is Believing
with an average price target of $13.84. This is a potential upside of $10.09 (269.07%) from yesterday's end of day stock price of $3.75.
VistaGen Therapeutics's activity chart (see below) currently has 5 price targets and 12 ratings on display.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 209 days.
Most recent stock forecast was given by ANDREW TSAI from JEFFERIES on 06-Dec-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$15
$10.93 (268.55%)
$6
1 years 10 months 25 days ago
(06-Dec-2023)
1/3 (33.33%)
$10.13 (208.01%)
27
Buy
$30
$25.93 (637.10%)
$30
2 years 1 months 27 days ago
(04-Sep-2023)
0/2 (0%)
$23.79 (383.09%)
Hold
$9
3 years 3 months 10 days ago
(22-Jul-2022)
1/1 (100%)
$6.42 (248.84%)
809
What is VTGN (VistaGen Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VTGN (VistaGen Therapeutics) with a proven track record?
Which analyst has the current lower performing score on VTGN (VistaGen Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VTGN (VistaGen Therapeutics)?
Which analyst is the currently most bullish on VTGN (VistaGen Therapeutics)?
Which analyst is the currently most reserved on VTGN (VistaGen Therapeutics)?